Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garassino, I [1 ]
Campagnoli, E. [1 ]
Cavina, R. [1 ]
Soto, Parra H. J. [1 ]
De Vincenzo, F. [1 ]
Zucali, P. A. [1 ]
Salamina, S. [1 ]
Ceresoli, G. L. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Dept Med Oncol & Hematol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [21] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
    Agelaki, S.
    Kontopodis, E. D.
    Kentepozidis, N.
    Giassas, S.
    Vamvakas, L.
    Androulakis, N.
    Kotsakis, K.
    Sfakiotaki, G.
    Mavroudis, D.
    Georgoulias, V
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
  • [22] Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer
    Khuri, FR
    Rigas, JR
    Figlin, RA
    Gralla, RJ
    Shin, DM
    Munden, R
    Fox, N
    Huyghe, MR
    Kean, Y
    Reich, SD
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2626 - 2637
  • [23] A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
    Lerouge, Delphine
    Riviere, Alain
    Dansin, Eric
    Chouaid, Christos
    Dujon, Cecile
    Schott, Roland
    Lavole, Armelle
    Le Pennec, Vincent
    Fabre, Elizabeth
    Crequit, Jacky
    Martin, Francis
    Dehette, Stephanie
    Fournel, Pierre
    Precheur-Agulhon, Benedicte
    Lartigau, Eric
    Zalcman, Gerard
    BMC CANCER, 2014, 14
  • [24] A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
    Delphine Lerouge
    Alain Rivière
    Eric Dansin
    Christos Chouaid
    Cécile Dujon
    Roland Schott
    Armelle Lavole
    Vincent Le Pennec
    Elizabeth Fabre
    Jacky Crequit
    Francis Martin
    Stéphanie Dehette
    Pierre Fournel
    Bénédicte Precheur-Agulhon
    Eric Lartigau
    Gérard Zalcman
    BMC Cancer, 14
  • [25] Vinorelbine (VNR)-cisplatin (CDDP)-carboplatin (CBDCA) combination in locally advanced or metastatic non-small cell lung cancer (NSCLC) plus phase II study
    Zylberait, D
    Charvolin, P
    Bernabeu, L
    Dumont, P
    Fallouh, H
    Biville, F
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 98
  • [26] GLOB 1: A phase III trial comparing the combination of vinorelbine and cisplatin (NP) versus vinorelbine, ifosfamide and cisplatin (NIP) in metastatic non small cell lung cancer patients (NSCLC).
    Souquet, PJ
    Huat, TE
    Pereira, JR
    Van Klaveren, R
    Price, A
    Gatzemeier, U
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
  • [27] A phase II study in Taiwan with navelbine (NVB) oral in combination with cisplatin (C) in advanced non-small cell lung cancer (NSCLC) patients
    Lefresne, F
    Chen, Y
    Yu, C
    Yang, C
    Perng, R
    Tsai, C
    Shih, J
    Cheng, A
    Pouget, J
    Yang, P
    LUNG CANCER, 2005, 49 : S255 - S256
  • [28] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
    Hasturk, S
    Hatabay, N
    Ece, F
    Karatas, M
    Hanta, I
    LUNG CANCER, 2005, 49 : S247 - S247
  • [29] Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): A multicentric randomised Phase II trial
    Comella, P
    Frasci, G
    Panza, N
    DeCataldis, G
    Cioffi, R
    Curcio, C
    Nicolella, D
    Micillo, E
    Ianniello, GP
    Biondi, E
    Perchard, J
    Comella, G
    LUNG CANCER, 1996, 15 (01) : 103 - 114
  • [30] A phase II study with cisplatin and vinorelbine in elderly patients with advanced Non-Small Cell Lung Cancer
    Lucio, Buffoni
    Davide, Ottaviani
    Alfredo, Addeo
    Vincenzo, Dongiovanni
    Raffaella, Grillo
    Camilla, Fissore
    Carla, Barone
    Diego, Dongiovanni
    Erika, Larovere
    Oscar, Bertetto
    ANNALS OF ONCOLOGY, 2005, 16 : 27 - 27
12345